News
Amgen combines patent protection, a robust pipeline, and strong execution for defensive investment. Click here to read an ...
Kathmere Capital Management increased its stake in Amgen by 48.9% in Q1, purchasing 1,491 more shares for $1.4M. Several ...
Shares of The Trade Desk received a nice bump in after-hours trading on July 14 after it was announced that the ad-tech company would be joining the S&P 500 beginning on July 18. The Trade Desk, which ...
For the second time in three years, Bob Bradway raked in the most of any executive of a public company based on the Central Coast in 2024, generating a total compensation package worth $24.4 million, ...
It’s called the Amgen Biotech Experience and for a number of teachers across the Piedmont, it could be the key to helping ...
1d
Zacks Investment Research on MSNAmgen (AMGN) is a Top-Ranked Growth Stock: Should You Buy?For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...
Genus Capital Management boldly acquired $6.3 million worth of Amgen shares during Q1, signaling confidence in the biotech giant’s trajectory. Amgen continues to attract large institutional investors, ...
The World Child Cancer (WCC) organisation has held its half-year review meeting of 2025 with stakeholders of its Haematology ...
Amgen Inc. closed 14.87% below its 52-week high of $346.85, which the company reached on July 25th.
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...
Monthly weight-loss shots on the horizon! Learn about new drugs like MariTide and why Black participation in clinical trials ...
A court battle between two of the nation’s largest biotechs is testing the legal limits of how far drugmakers can go in using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results